A drug development company with an innovative model for Clinical Development.
We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to market.
Location: United Kingdom, England, London
Member count: 11-50
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Abingworth... | abingworth... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 28.01.2013 | Avillion R... | Avillion LLP, a London, UK-bas... | funding U... | - | finsmes.co... |